Ataluren - CAS 775304-57-9

Ataluren (PTC124) is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk.

Autophagy, CFTR

Membrane transporter/Ion channel, Autophagy

775238

0.9984

C15H9FN2O3

284.24

FC1=C(C2=NC(=NO2)C3=CC(C(O)=O)=CC=C3)C=CC=C1

-20°C

Ice Packs

Small Compound